RecruitingNot ApplicableNCT07318038

The Use of Rhythmic Light Therapy in Mild Cognitive Impairment


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

20 participants

Start Date

Dec 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this within-subjects, crossover study, participants will undergo Electroencephalogram (EEG) recordings before, during, and after each of three 1-hour sessions. All participants will experience all three conditions: (1) dual-frequency visual (10 and 40 Hz), (2) single-frequency visual (40 Hz), and (3) non-rhythmic stimulation. EEG spectral power and amplitude coupling will be analyzed to determine whether stimulation-induced increases in alpha-gamma neural synchrony translate to improvements in cognitive performance.


Eligibility

Min Age: 55 YearsMax Age: 80 Years

Inclusion Criteria1

  • History of Mild Cognitive Impairment with a Montreal Cognitive Assessment score between 18 and 25

Exclusion Criteria4

  • History of epilepsy or photosensitivity
  • Blindness or other obstructive vision conditions
  • retinal diseases
  • presence of another brain disease accounting for their cognitive status

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFlickering Light

Red Flickering Light programed to three different visual stimulations


Locations(1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07318038


Related Trials